CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference

Rhea-AI Summary

CorMedix Inc. (NASDAQ: CRMD), a biopharmaceutical company specializing in therapeutic products for life-threatening diseases, has announced its participation in the upcoming Jefferies Global Healthcare Conference. The event will be held in New York from June 3-5, 2025. The company is scheduled to deliver a presentation on Thursday, June 5, 2025, at 3:45 p.m. EDT. A webcast of the presentation will be made available for interested parties.

BERKELEY HEIGHTS, N.J., May 30, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, will be participating in the Jefferies Global Healthcare Conference, taking place in New York on June 3 - 5, 2025.

Jefferies Global Healthcare Conference
Date:	Thursday, June 5, 2025
Time:	3:45p.m. EDT
Format:	Presentation
Webcast:	Link

About CorMedix

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath^® (taurolidine and heparin) which was approved by the FDA on November 15, 2023. CorMedix commercially launched DefenCath in inpatient settings in April 2024 and in outpatient settings in July 2024. CorMedix is commencing clinical studies in adult Total Parenteral Nutrition (TPN) patients and pediatric hemodialysis (HD) patient populations in 2025 and also intends to develop DefenCath as a catheter lock solution for use in other therapeutic areas. For more information visit: www.cormedix.com. 

Investor Contact:
Dan Ferry
Managing Director
LifeSci Advisors
daniel@lifesciadvisors.com 
(617) 430-7576

FAQ

When is CorMedix (CRMD) presenting at the Jefferies Global Healthcare Conference 2025?

CorMedix is scheduled to present on Thursday, June 5, 2025, at 3:45 p.m. EDT.

Where is the Jefferies Global Healthcare Conference 2025 being held?

The conference is taking place in New York from June 3-5, 2025.

What type of company is CorMedix (CRMD)?

CorMedix is a biopharmaceutical company that develops and commercializes therapeutic products for life-threatening diseases and conditions.

What is the format of CorMedix's participation at the Jefferies Healthcare Conference?

CorMedix will be delivering a presentation at the conference, which will be available via webcast.